Cargando…
Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment
PURPOSE: Perioperative systemic treatment has significantly improved the outcome in locally advanced esophagogastric cancer. However, still the majority of patients relapse and die. Data on the optimal treatment after relapse are limited, and clinical and biological prognostic factors are lacking. M...
Autores principales: | Apostolidis, Leonidas, Lang, Kristin, Sisic, Leila, Busch, Elena, Ahadova, Aysel, Wullenkord, Ramona, Nienhüser, Henrik, Billeter, Adrian, Müller-Stich, Beat, Kloor, Matthias, Jaeger, Dirk, Haag, Georg Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020279/ https://www.ncbi.nlm.nih.gov/pubmed/35441345 http://dx.doi.org/10.1007/s00432-022-04016-y |
Ejemplares similares
-
Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up
por: Stelmach, Ramona, et al.
Publicado: (2023) -
Clinical Characteristics and Oncological Outcomes of Surgically Treated Early-Onset Gastric Adenocarcinoma - a Retrospective Cohort Study
por: Rompen, Ingmar F., et al.
Publicado: (2023) -
Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective
por: Sisic, Leila, et al.
Publicado: (2023) -
Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review
por: Bohaumilitzky, Lena, et al.
Publicado: (2020) -
Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer
por: Blank, Susanne, et al.
Publicado: (2017)